Acumen Pharmaceuticals (ABOS) Share-based Compensation Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | -3.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.15% |
| Dec 31, 2025 | 3.24% |
| Sep 30, 2025 | 5.26% |
| Jun 30, 2025 | 1.13% |
| Mar 31, 2025 | -0.40% |
| Dec 31, 2024 | 43.39% |
| Sep 30, 2024 | 46.12% |
| Jun 30, 2024 | 62.39% |
| Mar 31, 2024 | 78.71% |
| Dec 31, 2023 | 84.01% |
| Sep 30, 2023 | 90.48% |
| Jun 30, 2023 | 112.73% |
| Mar 31, 2023 | 124.92% |
| Dec 31, 2022 | 143.29% |
| Sep 30, 2022 | 176.32% |
| Jun 30, 2022 | 462.99% |
| Mar 31, 2022 | 390.48% |
| Dec 31, 2021 | 860.53% |
| Sep 30, 2021 | 679.49% |